8-K
filed May 26, 2026, 8:36 PM ET
ticker NWSA
CIK 0001564708
other material
confidence high
sentiment neutral
materiality 0.40
News Corp repurchased 70K Class A and 30K Class B shares on May 26, 2026
NEWS CORP
- Class A (NWSA): 70,004 shares repurchased for ~$1.82M; highest price $26.25, lowest $25.81.
- Class B (NWS): 30,471 shares repurchased for ~$0.91M; highest price $30.00, lowest $29.56.
- Cumulative spend under $1B 2025 Repurchase Program is ~$268.6M (both classes combined).
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001564708-26-000115
- form_type
- 8-K
- ticker
- NWSA
- cik
- 0001564708
- company_name
- NEWS CORP
- filed_at
- 2026-05-27T00:36:07+00:00
- discovered_at
- 2026-05-27T10:05:00.237207+00:00
- generated_at
- 2026-05-27T10:07:32.632560+00:00
- sec_items
- ["8.01", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.4
- calibrated_materiality_score
- 0.4
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001564708-26-000115
- json_url
- https://secwatch.observer/filing/0001564708-26-000115.json
- markdown_url
- https://secwatch.observer/filing/0001564708-26-000115.md
- text_url
- https://secwatch.observer/filing/0001564708-26-000115.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1564708/000156470826000115/0001564708-26-000115-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1564708/000156470826000115/nws-20260526.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
EMYB
Embassy Bancorp expands stock repurchase program by additional $5M
Embassy Bancorp, Inc.
June 1, 2026, 4:37 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CTXR
Citius Oncology reports Phase 1 combo data: 24% ORR, 33% in endometrial cancer; Phase 2 planned
Citius Pharmaceuticals, Inc.
June 1, 2026, 4:30 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
ONCY
Oncolytics reports positive initial preclinical data for pelareorep + RAS inhibitors; further studies planned
ONCOLYTICS BIOTECH INC
June 1, 2026, 9:06 AM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CRM
Salesforce shareholders approve 34M share equity plan increase, extend term to 2036, all directors re-elected
Salesforce, Inc.
June 1, 2026, 4:43 PM ET
other_material
Items 5.07, 5.02, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
MXL
MaxLinear dismisses Grant Thornton, appoints KPMG as auditor for FY2026
MAXLINEAR, INC
June 1, 2026, 4:35 PM ET
other_material
Items 4.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
LXU
LSB Industries accelerates Pryor, OK turnaround start to May 28, 2026
LSB INDUSTRIES, INC.
June 1, 2026, 4:35 PM ET
other_material
Items 8.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
SMC
Summit Midstream Corporation announces inaugural $35 million stock repurchase program
Summit Midstream Corp
June 1, 2026, 4:31 PM ET
other_material
Items 7.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
BRANDYWINE OPERATING PARTNERSHIP, L.P.
Brandywine extends revolver maturity to Dec 2026; shareholders OK 5M share increase for LTIP
BRANDYWINE OPERATING PARTNERSHIP, L.P.
June 1, 2026, 4:30 PM ET
other_material
Items 1.01, 2.03, 5.02, 5.07, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.